Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

With Celgene Deal, Forma Makes First Foray Into Clinical Development

Apr 29 2013

• By Chris Morrison

Related Content

Boehringer, Forma Strike Discovery Deal In Oncology

Jan 06 2012

Celgene Licenses Lead Program From Epizyme, Takes Option To Remaining Pipeline

Apr 26 2012

Forma To Play To Its Strengths WIth Genentech Deal

Jul 01 2011

Servier Research Deals Suggest Business-As-Usual For Scandal-Ridden Firm

Oct 12 2011

The Next Big Thing In Drug Development May Be The Ubiquitin Pathway

Apr 01 2010

Related Companies

Forma Therapeutics Inc.

Bristol Myers Squibb Company

City of Hope

Cubist Pharmaceuticals, Inc.

Eisai Co., Ltd.

Novartis AG

Johnson & Johnson

Johnson & Johnson

Boehringer Ingelheim GmbH

Genentech, Inc.

Roche Holding AG

Takeda Pharmaceutical Co. Ltd.

Onyx Pharmaceuticals, Inc.

Proteostasis Therapeutics, Inc.

Hybrigenics Pharma

Genetix Biotherapeutics

Sutro Biopharma, Inc.

AnaptysBio, Inc.

Inhibrx, Inc.

Epizyme, Inc.

Bristol Myers Squibb Company

VentiRx Pharmaceuticals, Inc.

Avila Therapeutics, Inc.

Agios Pharmaceuticals, Inc.

Acceleron Pharma, Inc.

Cubist Pharmaceuticals, Inc.

Additional Topics

Business Strategies Deals BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window